New Search

If you are not happy with the results below please do another search

1271 search results for:

1161

Alzheimer markers assays

The Lumipulse G pTau 181 and β-Amyloid 1-40 assays are the latest additions to Fujirebio’s fully automated Neuro product line and complement the previously launched Lumipulse G Total Tau and β-Amyloid 1-42 assays. These assays are intended to measure β-Amyloid1-42, β-Amyloid1-40, total Tau and pTau181 in cerebrospinal fluid (CSF). Altogether, these four CSF markers support […]

1162

VACUETTE CAT Serum Fast Tube

Greiner Bio-One’s new VACUETTE CAT Serum Fast Tube is the optimal tube whenever results are needed fast. It enables serum to be analysed as quickly as plasma. The tube is coated with a mixture of Blood Clotting Activator (BCA) and thrombin. Thrombin, as an accelerator, speeds up the coagulation process: coagulation takes just five minutes, […]

1163

Automated plate streaking system

Beckman Coulter Diagnostics and NTE-SENER, the brand of the SENER group active in the field of healthcare technology, are partnering to enhance microbiology laboratory efficiency and effectiveness with the DxM 6100 Autoplak Advanced automated plate streaking system. The agreement between the two companies took effect June 16, 2017, making Beckman Coulter the sole distributor of […]

1164

Automated evaluation of IFA for infection diagnosis

The EUROPattern system has been extended to include computer-aided evaluation of indirect immunofluorescence assays (IFA) for infectious disease diagnosis. Parameters encompass Chlamydia spp., Bartonella spp., Mycoplasma spp., HHV-6, CHIKV, coxsackievirus, EBV, DENV, hantaviruses, sandfly fever viruses, YFV and ZIKV. The assays utilize infected cells, antigen-expressing cells or bacterial smears to detect the corresponding antibodies in […]

1165

Carbapenemase variants detection test

Surveillance and control of resistance to beta-lactam among gram-negative bacteria remains nowadays a big concern for microbiologists worldwide. Descriptions of OXA-48 associated infections are still revealing huge impact on antimicrobial treatment and patient morbidity. For clinical laboratories, OXA-48 and its variants represent the most challenging resistance mechanism to detect and are often under-detected by routine […]

1166

Multiplex molecular diagnostic platform

Qiagen has announced the launch of QIAstat-Dx in Europe, providing a one-step, fully integrated molecular analysis of common syndromes as tested for in infections, oncology and other diseases. The launch follows the closing of the acquisition of Stat-Dx announced in January 2018 and the successful completion of defined development activities by Stat-Dx. QIAstat-Dx (formerly Stat-Dx […]

1167

Versatile tube holder with male luer lock

The new VACUETTE SAFELINK tube holder facilitates quick and easy blood collection. The tube can be used in combination with all medical products that have a standard female luer lock connection, such as winged cannulae. Above all, it is characterized by its simple handling.The luer lock feature sets the VACUETTE SAFELINK apart from the conventional […]

1168

Combined detection of anti-Zika virus IgAM in acute infections

A new ELISA provides parallel detection of anti-Zika virus antibodies of classes IgA and IgM against the highly specific viral non-structural protein (NS-1). Anti-Zika virus NS-1 antibodies of class IgA are a novel alternative indicator of acute infection, and their detection is particularly useful in cases where IgM is not detectable. This can occur, for […]

1169

ELISAs for differentiation of acute and chronic Q fever

A new range of ELISAs provides differentiated analysis of antibodies against Coxiella burnetii, the causative agent of Q fever. According to Immunological Methods for the Detection of Infectious Diseases (MiQ. 2017), separate detection of antibodies against phase 1 and phase 2 antigens of C. burnetii is recommended to aid discrimination of acute and chronic infections. […]

1170

S. pneumoniae and L. pneumophila rapid test

Streptococcus pneumoniae is the leading cause of community-acquired pneumonia and Legionella pneumophila causes costly hospital and ICU admissions. It is difficult to clinically distinguish between the two bacteria and due to different treatment of the diseases, guidelines recommend double testing. The ImmuView Antigen test makes it now possible to readily distinguish between both microorganisms in […]